iVR1

N/A

Report date: 2025/01/26 15:56:34

Base Information

Drug NameiVR1
Drug Alias NameVEFGR-1 inhibitor (Institute of Genetics and Biophysics)VEFGR-1 inhibitor (Anbition)anti-angiogenic tetrameric tripeptide (Anbition)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor 1 antagonists
TargetsVascular endothelial growth factor receptor 1
Therapy Area/IndicationsChoroidal NeovascularizationMacular DegenerationColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Genetics And Biophysics Cnr
China Registration ClassN/A

Develop Information

Active CompaniesAnbition Srl
Inactive CompaniesInstitute Of Genetics And Biophysics Cnr
Active IndicationsChoroidal NeovascularizationMacular DegenerationColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A